Nuzenio

Supernus Pharmaceuticals

Supernus Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 17 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 11:44:17 GMTSupernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Sat, 08 Aug 2026 05:18:55 GMTSupernus Pharmaceuticals (NASDAQ:SUPN) Cut to "Hold" at Wall Street Zen - MarketBeat
Fri, 07 Aug 2026 15:21:00 GMTSupernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN - Business Wire
Thu, 06 Aug 2026 22:49:12 GMTMillennium group (SUPN) reports Supernus stake falls below 5% ownership - Stock Titan
Thu, 06 Aug 2026 13:33:55 GMTRx Rundown: Supernus Pharmaceuticals, TCGX, Sandoz and more - Medical Marketing and Media
Thu, 06 Aug 2026 06:36:02 GMTSupernus Pharmaceuticals (SUPN) Jumps On Merger Terms, Is The Stock Still Cheap? - simplywall.st

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Supernus Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.